Fine particulate matter related to multiple sclerosis relapse in young patients

Young Investigator
Edouard Januel
Hopital Saint-Antoine
66
Paris, France

Abstract

Objective:
Particulate matter (PM) of aerodynamic diameter smaller than 10 μm (PM10) has been associated with multiple sclerosis (MS) relapse. However, the impact of smaller PM with a greater ability to penetrate human organism has never been assessed. We evaluated the impact of PM smaller than 2.5 μm (PM2.5) on the risk of MS relapse.

Material and methods:
In a case-crossover study, we included 2109 consecutive hospitalizations for MS relapse in day hospital in 5 MS centers in the Paris area from January 2009 to December 2013. For each hospitalization, the natural logarithm of the average weekly PM2.5 concentrations (μg/m3 ) at the patient’s residence address during each of the six weeks (week[0] to week[-5]) preceding admission was compared with the concentration during the previous week, using a conditional logistic regression adjusted on temperature, flu like syndrome rate, pollen count, and holiday period.

Results:
PM2.5 average concentration during week[-3] was significantly associated with the risk of hospitalization for MS relapse (OR=1.21 [CI 1.01;1.46]). The association was stronger in patients younger than 30 years (OR=1.77 [CI 1.10;2.83]).

Conclusion:
Our study demonstrates for the first time an association between exposure to PM2.5 and MS relapse, particularly in young people.

Fine particulate matter related to multiple sclerosis relapse in young patients

Edouard Januel1, Boris Dessimond2, Augustin Colette3, Isabella Annesi-Maesano*2, Bruno Stankoff*1,4
*These authors contributed equally to the manuscript.

1Assistance Publique des Hôpitaux de Paris, APHP, Hôpital Saint Antoine, Neurology Department ; 2Sorbonne Université and INSERM, Épidémiologie des maladies Allergiques et Respiratoires, Institut Pierre Louis d'Epidémiologie et Santé Publique ; 3Atmospheric
Modelling and Environmental Mapping Unit, INERIS, BP2, Verneuil-en-Halatte, 60550, France ; 4Sorbonne Universités, Brain and Spine Institute, ICM, Hôpital de la Pitié Salpêtrière, Inserm UMR-S 1127, CNRS UMR 7225, Paris, France